Mol. Cells 2022; 45(11): 820-832
Published online September 28, 2022
https://doi.org/10.14348/molcells.2022.2042
© The Korean Society for Molecular and Cellular Biology
Correspondence to : jungkim@cau.ac.kr(JWK); kpkim@cau.ac.kr(KPK)
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.
As a potential candidate to generate an everlasting cell source to treat various diseases, embryonic stem cells are regarded as a promising therapeutic tool in the regenerative medicine field. Cohesin, a multi-functional complex that controls various cellular activities, plays roles not only in organizing chromosome dynamics but also in controlling transcriptional activities related to self-renewal and differentiation of stem cells. Here, we report a novel role of the α-kleisin subunits of cohesin (RAD21 and REC8) in the maintenance of the balance between these two stem-cell processes. By knocking down REC8, RAD21, or the non-kleisin cohesin subunit SMC3 in mouse embryonic stem cells, we show that reduction in cohesin level impairs their self-renewal. Interestingly, the transcriptomic analysis revealed that knocking down each cohesin subunit enables the differentiation of embryonic stem cells into specific lineages. Specifically, embryonic stem cells in which cohesin subunit RAD21 were knocked down differentiated into cells expressing neural alongside germline lineage markers. Thus, we conclude that cohesin appears to control the fate determination of embryonic stem cells.
Keywords cohesin, embryonic stem cells, RAD21, REC8, trascriptomic analysis
Controlled differentiation of embryonic stem cells (ESCs) to specific lineages has long been considered innovative in the field of regenerative medicine, with the merit that they may serve as an everlasting cell source to treat debilitating diseases once considered incurable (Keller, 2005; Murry and Keller, 2008; Sobhani et al., 2017). However, the major challenge in this strategy is the generation of physiological cells (Efthymiou et al., 2014; Findikli et al., 2006; Gorecka et al., 2019).
ESCs are pluripotent cells, which can differentiate into every cell type in the embryo and have the ability of self-renewal (Subramanian et al., 2009; Walker et al., 2007; Zakrzewski et al., 2019). Thus, these cells have been regarded as a promising therapeutic tool against various degenerative diseases, but the mechanisms underlying these two properties of ESCs are still under investigation (Heng et al., 2004; Vazin and Freed, 2010; Young, 2011). Therefore, a comprehensive approach to understanding these mechanisms is essential to harness the pluripotency of ESCs for clinical applications. In the past decades, many studies have focused on strategies that control the expression of genes related to ESC self-renewal, and increasing evidence suggests a role of cohesin in ESC differentiation (Cuartero et al., 2018; Kagey et al., 2010; Noutsou et al., 2017).
As eukaryotic cells have distinct time gaps between the time of chromosome duplication and segregation, cell division must be strictly regulated to distribute one copy of each duplicated chromosome to each daughter cell (Brooker and Berkowitz, 2014; Choi et al., 2017; Mehta et al., 2012). The cohesin complex is known to be essential for the accurate distribution of chromosomes to daughter cells. Regarded as a “molecular glue,” cohesin uses its tripartite ring-shaped structure to entrap the duplicated chromosome until anaphase (Peters et al., 2008). This protein complex is composed of four core subunits, which include the structural maintenance of chromosomes (SMC) proteins SMC1A and SMC3, the kleisin protein RAD21, and the stromal antigen (SA) protein SA1/STAG1 or SA2/STAG2 (Nasmyth and Haering, 2009). In addition, mammalian meiosis-specific cohesin components, which include SMC1β, RAD21L, REC8, and SA3/STAG3 (Biswas et al., 2016; Choi et al., 2022; Hong et al., 2019; Ishiguro, 2019). Recently, Choi et al. (2022) have demonstrated that the components of meiosis-specific cohesin are expressed in ESCs as well and play a role in the chromosomal organization and sister-chromatid cohesion. Given that the cohesin complex has diverse roles in organizing chromosome dynamics and transcriptional activities related to ESC self-renewal and differentiation (Kagey et al., 2010; Noutsou et al., 2017), it is truly positioned as a multi-functional complex that controls various cellular activities. Although the role of cohesin in chromosome dynamics has been well studied (Han et al., 2021; Hirano, 2015; Revenkova et al., 2004), its role in regulating ESC differentiation remains unclear.
In this study, we reveal that cohesin may function to maintain the balance between ESC self-renewal and differentiation. Based on the RNA-sequencing data, we determined that knocking down each cohesin factor not only accelerated the differentiation of ESCs but also induced their differentiation into specific lineages. We used four transcriptional factors known to be essential for maintaining the pluripotency of ESCs—Oct4 (Pou5f1), Nanog, Sox2, and Klf4 (Takahashi and Yamanaka, 2006). By using these transcriptional factors, we observed reduced expression of cohesin accelerated differentiation of ESC when compared with the control group. We then examined the lineage of the differentiated cells by characterizing their expression patterns of specific markers commonly used for lineage determination. Accordingly, knocking down cohesin subunits induced ESC differentiation into diverse cell types with markers of specific lineages. Harnessing this ability of cohesin can provide new approaches for controlled differentiation of ESCs and new insights for regenerative medicine and tissue engineering.
The J1 mouse ESCs were derived from the inner cell mass of a male agouti 129S4/SvJae embryo. These cells (mESCs) were used in all the experiments presented in this article. mESCs were maintained in DMEM High Glucose (10566016; Gibco, USA) with 10% horse serum (16050122; Gibco), 2 mM L-glutamine (25030081; Gibco), 10 mM HEPES (15630080; Gibco), 0.1 mM beta-mercaptoethanol (31350010; Gibco), 0.1 mM MEM Non-Essential Amino Acids (11140050; Gibco), 100 U/ml penicillin-streptomycin (10378016; Gibco), and 103 U/ml ESGRO Recombinant Mouse Leukemia Inhibitory Factor (LIF) (ESG1107; Millipore, USA). Cells were cultured in a humidified 5% CO2 incubator at 37°C.
Individual cultured cells were used for the sample preparation. mESCs were differentiated in DMEM High Glucose (10566016) with 10% horse serum (16050122), 2 mM L-glutamine (25030081), 10 mM HEPES (15630080), 0.1 mM beta-mercaptoethanol (31350010), 0.1 mM MEM Non-Essential Amino Acids (11140050), 100 U/ml penicillin-streptomycin (10378016) for 96 h. LIF was excluded in culture media to induce differentiation of mESCs.
RNA sample used in this study was extracted using RNeasy Mini Kit (74104; Qiagen, Germany). Total RNA was purified from mESCs. After cell lysis and homogenization, the lysates were loaded onto the RNeasy silica membrane. Any residual DNA was removed through on-column DNase treatment. Purified RNA was eluted using RNase-free DEPC water. All the procedures followed the directions of the manufacturers. RNA quality and quantity were assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies, The Netherlands) and ND-2000 Spectrophotometer (Thermo Fisher Scientific, USA), respectively.
Libraries were prepared from total RNA by using the NEBNext Ultra II Directional RNA-Seq Kit (NEW ENGLAND BioLabs, UK). Poly(A)-tailed mRNAs were isolated using a Poly(A) RNA Selection Kit (LEXOGEN, Austria). The isolated mRNAs were used for the synthesis of cDNA, which was then sheared, following the manufacturer’s instructions. Indexing was performed using the Illumina indices 1-12 (Illumina, USA). The enrichment step was carried out using polymerase chain reaction (PCR). Subsequently, libraries were checked using the Agilent 2100 bioanalyzer (DNA High Sensitivity Kit) to evaluate the mean fragment size. Quantification was performed using the library quantification kit using a StepOne Real-Time PCR System (Life Technologies, USA). High-throughput sequencing (paired-end 100 bp) was performed using HiSeq ×10 (Illumina).
Quality control of the raw sequencing data was performed using FastQC. Adapter and low-quality reads (
The differential gene expression pattern between asynchronous ESCs and knocked-down mESCs was analyzed using GSEA (ver. 4.1.0) and C5 gene sets, which encompass genes annotated via the same ontology term. The normalized enrichment scores were based on normalized Kolmogorov–Smirnov statistics, and
The primary antibodies were rabbit anti-REC8 (ab192241; Abcam, UK), rabbit anti-RAD21 (ab154769; Abcam), rabbit anti-SMC3 (ab9263; Abcam), mouse anti-OCT3/4 (sc5297; Santa Cruz Biotechnology, USA), and rabbit anti–α-tubulin (ab4074; Abcam). The secondary antibodies were AffiniPure goat anti-rabbit IgG (H+L) (111-005-003; Jackson ImmunoResearch, USA) and AffiniPure goat anti-mouse IgG (H+L) (115-005-003; Jackson ImmunoResearch).
The following commercially available pre-designed small-interfering RNAs (siRNAs) were purchased from Bioneer (Korea) and used to knock down the target genes:
Lipofectamine RNAiMAX transfection reagent (13778; Invitrogen, USA) was used to transfect mESCs with the siRNAs. mESCs were seeded in a 60-mm cell culture dish at a density of 2 × 105 cells and transfected with each siRNA by using Lipofectamine RNAiMAX and Opti-MEM™ Reduced Serum Medium, GlutaMAX™ Supplement (51985034; Gibco) according to the instructions of the manufacturers. AccuTarget™ Negative Control siRNA (SN-1003; Bioneer) was used as a negative control.
Cells were lysed in the cell lysis buffer (50 mM Tris-HCl [pH 7.5], 300 mM NaCl, 0.05% NP40, 5 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, and protease inhibitor cocktail). Lysates (30-50 µg total protein) were electrophoresed on an 8%-10% SDS-polyacrylamide gel, and then the resolved proteins were transferred onto a PVDF (polyvinylidene difluoride) membrane. Membranes were blocked with 5% skim milk in Tris-buffered saline (TBS) with 0.1% Tween 20 and incubated with primary antibodies against REC8 (1:3,000), RAD21 (1:5,000), SMC3 (1:5,000), OCT3/4 (1:3,000), and α-TUBULIN (1:10,000) overnight at 4°C. Membranes were washed with TBS containing 0.1% Tween 20 three times for 10 min and incubated with the secondary antibody for 1 h at 23°C. The membranes were washed three times with TBST (TBS with 0.1% Tween 20) for 10 min each and developed using an ECL system (170-5061; Bio-Rad, USA) according to the manufacturer’s directions. Immunoblot detection was conducted using the ChemiDoc MP Imaging system (Bio-Rad).
Quantitative PCR was used for analyzing the expression levels of the target genes. SYBR Green (K-6251; Bioneer) and the CFX Connect Real-Time PCR system (1855201; Bio-Rad) were used for the experiments. The sequences of the primers used are listed in Supplementary Table S1.
Data were analyzed using the Prism 5 software (GraphPad Software, USA) and are illustrated as mean ± SD. Statistically significant differences between various groups were measured using the Student’s
The RNA-Seq data were deposited into the NCBI Sequence Read Archive. All the RNA-Seq reads are available under the following accession numbers: SRX10686134 (https://www.ncbi.nlm.nih.gov/sra/?term=SRX10686134), SRX10686135 (https://www.ncbi.nlm.nih.gov/sra/?term=SRX10686135), SRX10686136 (https://www.ncbi.nlm.nih.gov/sra/?term=SRX10686136), and SRX10686137 (https://www.ncbi.nlm.nih.gov/sra/?term=SRX10686137).
The ultimate role of stem cells is defined in terms of their developmental capacity measured by their differentiation ability (Choi et al., 2020; Zhang and Wang, 2008). The role of cohesin against ESC differentiation has previously been shown (Choi et al., 2022; Khaminets et al., 2020; Noutsou et al., 2017), but whether changes in gene expression are a cause or consequence of promoting ESC self-renewal remains unclear. To define the role of cohesin in regulating ESC differentiation, we depleted the core subunit SMC3 and the kleisin subunit RAD21. We additionally depleted the meiotic cohesin component REC8, which was recently shown to play diverse roles in ESCs (Choi et al., 2022). Depletion of each factor was conducted by treating siRNAs against SMC3, RAD21, and REC8 in ESCs. To investigate the role of cohesin in ESC differentiation, we asked whether knocking down each cohesin subunit promoted ESC differentiation (Fig. 1A). To identify protein expression level, we conducted western blot analysis to examine the knockdown efficiency of cohesin as well as the expression level of OCT3/4, which is commonly used as a stem cell marker. (Fig. 1B). The knockdown efficiency of each cohesin subunit in ESCs was higher than 50%, compared with the subunit levels in the siControl condition (Supplementary Fig. S1A). Additionally, knocking down each cohesin subunit did not influence the expression levels of the other subunits (Supplementary Fig. S1B). Interestingly, relative expression levels of OCT3/4 to GAPDH were drastically decreased in cohesin-knockdown conditions compared with the levels in the control group, meaning that each cohesin subunit, especially RAD21 and SMC3, somehow decreases the level of OCT3/4, raising the possibility that it stimulates the differentiation of ESCs (Fig. 1C; Choi et al., 2022). Further, we investigated quantitative PCR to identify the expression pattern of pluripotency transcription factors OCT3/4, SOX2, KLF4, and NANOG in cohesin-knockdown conditions. As shown in the western blot results, we found decreased expression of the stemness markers in cohesin-knockdown conditions. Whereas every cohesin-knockdown condition showed decreased expression of pluripotency transcription factors, si
Several studies have suggested the role of cohesin in changing chromatin architecture, especially those of key self-renewal–related genes (Haering and Jessberger, 2012; Kagey et al., 2010; Noutsou et al.,2017; Sofueva et al., 2013). As the knockdown of each cohesin subunit promoted ESC differentiation, mRNA sequencing (RNA-seq) was performed to verify the differences in global gene expression patterns between the control and cohesin-knockdown groups. To minimize the possibility of misinterpretations, we analyzed RNA-seq data from two independent experiments. PCA (principal component analysis) was used to interpret the suitability of the two independent experiments as biological replicates, as well as the association between each sample (Fig. 2A). The similarity between the two independent groups was high enough to use them as biological replicates, and each group showed distinct distances between one another, meaning that each group has a different gene expression pattern (Supplementary Fig. S2). For further study, a Venn diagram displaying the upregulated and downregulated transcripts was generated based on the normalized data with FPKM > 1, fold change > 1.5, and
The correlation of cohesin with differentiation has been studied by several groups (Galeev et al., 2016; Khaminets et al., 2020; Viny et al., 2019), yet the role of cohesin in controlling ESC differentiation has not been elucidated. As we identified the fact that cohesin regulates the differentiation pattern, we decided to assess the genes whose expression was differentially regulated in each cohesin subunit knockdown condition. To investigate the differentiation pattern in the context of cohesin loss, we decided to analyze the genes whose expression levels are differentially regulated in the si
To identify if REC8 knockdown induces circulatory system development, we classified five related GO terms to understand the gene expression pattern of each group. The five terms are as follows: positive regulation of cell differentiation, anatomical structure formation involved in morphogenesis, blood vessel morphogenesis, vasculature development, and circulatory system development. The set-to-set analysis was performed to understand the correlation among the five groups. “Blood vessel morphogenesis,” “vasculature development,” and “circulatory system development” showed high intensity, as these terms could be grouped by the term “angiogenesis.” Intriguingly, the genes enriched in the term “anatomical structure formation involved in morphogenesis” showed a strong correlation with angiogenesis-related groups, as mentioned above. Indeed, a heatmap of leading-edge genes in each group revealed a fair number of genes co-regulated in each group (Fig. 3D). Meanwhile, groups of genes in positive regulation of cell differentiation with other groups showed a lower intensity of interaction, showing a relatively less overlap among the leading-edge genes (Fig. 3C). To test which genes are in charge of regulating lineage-specific differentiation, a heatmap of leading-edge genes in each group was generated (Fig. 3D). Above all, the
As each GO term contains redundant overlapping genes, we analyzed each GO term and chose two terms that represent functional attributes of the si
Although ESC is characterized by pluripotency and self-renewal, our result reveals that knocking down cohesin in ESC induces lineage-specific differentiation
ESCs in each cohesin subunit knockdown condition were further differentiated to characterize the identity of final differentiated cell populations. For this analysis, we used real-time PCR to determine whether differentiated cells in the cohesin-knockdown conditions express lineage-specific markers. Neural and germline lineage markers turned out to be highly expressed in differentiated cells of the si
Since the development of the methods that control the differentiation of ESCs into specific lineages is of interest, the field of stem cell research has been the center of attention given the ability of ESCs to differentiate into every somatic cell type in the embryo proper. With the expectation of serving as an everlasting cell source to generate functional cells, the harnessing of ESCs is considered a promising therapeutic strategy to treat diverse human diseases. Therefore, several studies are being done to improve the effectiveness of differentiation of ESCs into specific cell types (Gamage et al., 2016; Potter et al., 2014; Willerth et al., 2006). The major limitations of this strategy are that the properties of ESCs and differentiated cells are not described in detail (Choumerianou et al., 2008; Steinbeck and Studer, 2015).
The cohesin complex is a multi-functional complex that exerts various biological processes ranging from organizing chromosome dynamics to controlling self-renewal activity and differentiation of ESCs. Several studies have described the correlation between cohesin and cell differentiation (Mazzola et al., 2019; Sasca et al., 2019), but its exact role in regulating ESC differentiation remains unclear. Through functional analysis of cohesin knockdown conditions, our findings suggest the novel role of cohesin that may function to maintain the balance of self-renewal and differentiation. By using four transcriptional factors that are known to be essential for maintaining the pluripotency of ESCs—Oct4 (Pou5f1), Nanog, Sox2, and Klf4 (Han et al., 2021; Takahashi and Yamanaka et al., 2006)—we aimed to identify the role of cohesin in the pluripotency of ESCs. Knockdown of each cohesin subunit showed decreased expression of pluripotency markers, but among them, si
As the role of cohesin in regulating self-renewal genes has been reported by several researchers, our identification has its further focus on the detailed networks between reduced expression of cohesin and the pattern of differentiation. Using RNA-seq, we performed the first transcriptomic analysis of ESCs in the cohesin-knockdown conditions and observed a significant association between each cohesin subunit knockdown and differentiation to a specific cell type. To address the global gene expression pattern, we identified the genes that were co-regulated in the cohesin-knockdown condition using the DAVID tool. DAVID analysis showed that genes that are up- or down-regulated showed highly enriched biological terms related to differentiation. As SMC3 is the core subunit of cohesin, we decided to analyze the si
Since differentiated cells exhibit specific genes that produce the proteins characteristic for each type of cell, we decided to use lineage markers to determine whether the cohesin-knockdown conditions regulate the lineage specification of differentiation or not. By using two markers for each lineage, we identified the expression levels of lineage-specific markers by comparing RNA-sequencing data of undifferentiated cells and quantitative PCR data of differentiated cells. The RNA-sequencing data revealed that except for the endothelium lineage marker GATA4, which showed a slight downregulation in the si
Taken together, our results indicate that these networks significantly contribute to the lineage differentiation of ESCs which is considered a major challenge for the clinical application of stem cells. While we cannot ignore the constraints of any unrevealed signaling pathway and its applicability
This work was supported by grants from the National Research Foundation of Korea, funded by the Ministry of Science, ICT & Future Planning (No. 2020R1A2C2011887; 2018R1D1A1B07050755), the Korea Environment Industry & Technology Institute through “Digital Infrastructure Building Project for Monitoring, Surveying and Evaluating the Environmental Health Program (No. 2021003330007)” funded by Korea Ministry of Environment, and the BioGreen 21 Program (No. PJ015708) funded by Rural Development Administration, Republic of Korea.
Y.E.K. performed the experiments. Y.E.K., E.H.C., J.W.K., and K.P.K. analyzed the data. K.P.K. conceived and supervised the study. All authors wrote and edited the manuscript.
The authors have no potential conflicts of interest to disclose.
Mol. Cells 2022; 45(11): 820-832
Published online November 30, 2022 https://doi.org/10.14348/molcells.2022.2042
Copyright © The Korean Society for Molecular and Cellular Biology.
Young Eun Koh1,2 , Eui-Hwan Choi1,3
, Jung-Woong Kim1,*
, and Keun Pil Kim1,*
1Department of Life Sciences, Chung-Ang University, Seoul 06974, Korea, 2Genexine Inc., Bio Innovation Park, Seoul 07789, Korea, 3New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea
Correspondence to:jungkim@cau.ac.kr(JWK); kpkim@cau.ac.kr(KPK)
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.
As a potential candidate to generate an everlasting cell source to treat various diseases, embryonic stem cells are regarded as a promising therapeutic tool in the regenerative medicine field. Cohesin, a multi-functional complex that controls various cellular activities, plays roles not only in organizing chromosome dynamics but also in controlling transcriptional activities related to self-renewal and differentiation of stem cells. Here, we report a novel role of the α-kleisin subunits of cohesin (RAD21 and REC8) in the maintenance of the balance between these two stem-cell processes. By knocking down REC8, RAD21, or the non-kleisin cohesin subunit SMC3 in mouse embryonic stem cells, we show that reduction in cohesin level impairs their self-renewal. Interestingly, the transcriptomic analysis revealed that knocking down each cohesin subunit enables the differentiation of embryonic stem cells into specific lineages. Specifically, embryonic stem cells in which cohesin subunit RAD21 were knocked down differentiated into cells expressing neural alongside germline lineage markers. Thus, we conclude that cohesin appears to control the fate determination of embryonic stem cells.
Keywords: cohesin, embryonic stem cells, RAD21, REC8, trascriptomic analysis
Controlled differentiation of embryonic stem cells (ESCs) to specific lineages has long been considered innovative in the field of regenerative medicine, with the merit that they may serve as an everlasting cell source to treat debilitating diseases once considered incurable (Keller, 2005; Murry and Keller, 2008; Sobhani et al., 2017). However, the major challenge in this strategy is the generation of physiological cells (Efthymiou et al., 2014; Findikli et al., 2006; Gorecka et al., 2019).
ESCs are pluripotent cells, which can differentiate into every cell type in the embryo and have the ability of self-renewal (Subramanian et al., 2009; Walker et al., 2007; Zakrzewski et al., 2019). Thus, these cells have been regarded as a promising therapeutic tool against various degenerative diseases, but the mechanisms underlying these two properties of ESCs are still under investigation (Heng et al., 2004; Vazin and Freed, 2010; Young, 2011). Therefore, a comprehensive approach to understanding these mechanisms is essential to harness the pluripotency of ESCs for clinical applications. In the past decades, many studies have focused on strategies that control the expression of genes related to ESC self-renewal, and increasing evidence suggests a role of cohesin in ESC differentiation (Cuartero et al., 2018; Kagey et al., 2010; Noutsou et al., 2017).
As eukaryotic cells have distinct time gaps between the time of chromosome duplication and segregation, cell division must be strictly regulated to distribute one copy of each duplicated chromosome to each daughter cell (Brooker and Berkowitz, 2014; Choi et al., 2017; Mehta et al., 2012). The cohesin complex is known to be essential for the accurate distribution of chromosomes to daughter cells. Regarded as a “molecular glue,” cohesin uses its tripartite ring-shaped structure to entrap the duplicated chromosome until anaphase (Peters et al., 2008). This protein complex is composed of four core subunits, which include the structural maintenance of chromosomes (SMC) proteins SMC1A and SMC3, the kleisin protein RAD21, and the stromal antigen (SA) protein SA1/STAG1 or SA2/STAG2 (Nasmyth and Haering, 2009). In addition, mammalian meiosis-specific cohesin components, which include SMC1β, RAD21L, REC8, and SA3/STAG3 (Biswas et al., 2016; Choi et al., 2022; Hong et al., 2019; Ishiguro, 2019). Recently, Choi et al. (2022) have demonstrated that the components of meiosis-specific cohesin are expressed in ESCs as well and play a role in the chromosomal organization and sister-chromatid cohesion. Given that the cohesin complex has diverse roles in organizing chromosome dynamics and transcriptional activities related to ESC self-renewal and differentiation (Kagey et al., 2010; Noutsou et al., 2017), it is truly positioned as a multi-functional complex that controls various cellular activities. Although the role of cohesin in chromosome dynamics has been well studied (Han et al., 2021; Hirano, 2015; Revenkova et al., 2004), its role in regulating ESC differentiation remains unclear.
In this study, we reveal that cohesin may function to maintain the balance between ESC self-renewal and differentiation. Based on the RNA-sequencing data, we determined that knocking down each cohesin factor not only accelerated the differentiation of ESCs but also induced their differentiation into specific lineages. We used four transcriptional factors known to be essential for maintaining the pluripotency of ESCs—Oct4 (Pou5f1), Nanog, Sox2, and Klf4 (Takahashi and Yamanaka, 2006). By using these transcriptional factors, we observed reduced expression of cohesin accelerated differentiation of ESC when compared with the control group. We then examined the lineage of the differentiated cells by characterizing their expression patterns of specific markers commonly used for lineage determination. Accordingly, knocking down cohesin subunits induced ESC differentiation into diverse cell types with markers of specific lineages. Harnessing this ability of cohesin can provide new approaches for controlled differentiation of ESCs and new insights for regenerative medicine and tissue engineering.
The J1 mouse ESCs were derived from the inner cell mass of a male agouti 129S4/SvJae embryo. These cells (mESCs) were used in all the experiments presented in this article. mESCs were maintained in DMEM High Glucose (10566016; Gibco, USA) with 10% horse serum (16050122; Gibco), 2 mM L-glutamine (25030081; Gibco), 10 mM HEPES (15630080; Gibco), 0.1 mM beta-mercaptoethanol (31350010; Gibco), 0.1 mM MEM Non-Essential Amino Acids (11140050; Gibco), 100 U/ml penicillin-streptomycin (10378016; Gibco), and 103 U/ml ESGRO Recombinant Mouse Leukemia Inhibitory Factor (LIF) (ESG1107; Millipore, USA). Cells were cultured in a humidified 5% CO2 incubator at 37°C.
Individual cultured cells were used for the sample preparation. mESCs were differentiated in DMEM High Glucose (10566016) with 10% horse serum (16050122), 2 mM L-glutamine (25030081), 10 mM HEPES (15630080), 0.1 mM beta-mercaptoethanol (31350010), 0.1 mM MEM Non-Essential Amino Acids (11140050), 100 U/ml penicillin-streptomycin (10378016) for 96 h. LIF was excluded in culture media to induce differentiation of mESCs.
RNA sample used in this study was extracted using RNeasy Mini Kit (74104; Qiagen, Germany). Total RNA was purified from mESCs. After cell lysis and homogenization, the lysates were loaded onto the RNeasy silica membrane. Any residual DNA was removed through on-column DNase treatment. Purified RNA was eluted using RNase-free DEPC water. All the procedures followed the directions of the manufacturers. RNA quality and quantity were assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies, The Netherlands) and ND-2000 Spectrophotometer (Thermo Fisher Scientific, USA), respectively.
Libraries were prepared from total RNA by using the NEBNext Ultra II Directional RNA-Seq Kit (NEW ENGLAND BioLabs, UK). Poly(A)-tailed mRNAs were isolated using a Poly(A) RNA Selection Kit (LEXOGEN, Austria). The isolated mRNAs were used for the synthesis of cDNA, which was then sheared, following the manufacturer’s instructions. Indexing was performed using the Illumina indices 1-12 (Illumina, USA). The enrichment step was carried out using polymerase chain reaction (PCR). Subsequently, libraries were checked using the Agilent 2100 bioanalyzer (DNA High Sensitivity Kit) to evaluate the mean fragment size. Quantification was performed using the library quantification kit using a StepOne Real-Time PCR System (Life Technologies, USA). High-throughput sequencing (paired-end 100 bp) was performed using HiSeq ×10 (Illumina).
Quality control of the raw sequencing data was performed using FastQC. Adapter and low-quality reads (
The differential gene expression pattern between asynchronous ESCs and knocked-down mESCs was analyzed using GSEA (ver. 4.1.0) and C5 gene sets, which encompass genes annotated via the same ontology term. The normalized enrichment scores were based on normalized Kolmogorov–Smirnov statistics, and
The primary antibodies were rabbit anti-REC8 (ab192241; Abcam, UK), rabbit anti-RAD21 (ab154769; Abcam), rabbit anti-SMC3 (ab9263; Abcam), mouse anti-OCT3/4 (sc5297; Santa Cruz Biotechnology, USA), and rabbit anti–α-tubulin (ab4074; Abcam). The secondary antibodies were AffiniPure goat anti-rabbit IgG (H+L) (111-005-003; Jackson ImmunoResearch, USA) and AffiniPure goat anti-mouse IgG (H+L) (115-005-003; Jackson ImmunoResearch).
The following commercially available pre-designed small-interfering RNAs (siRNAs) were purchased from Bioneer (Korea) and used to knock down the target genes:
Lipofectamine RNAiMAX transfection reagent (13778; Invitrogen, USA) was used to transfect mESCs with the siRNAs. mESCs were seeded in a 60-mm cell culture dish at a density of 2 × 105 cells and transfected with each siRNA by using Lipofectamine RNAiMAX and Opti-MEM™ Reduced Serum Medium, GlutaMAX™ Supplement (51985034; Gibco) according to the instructions of the manufacturers. AccuTarget™ Negative Control siRNA (SN-1003; Bioneer) was used as a negative control.
Cells were lysed in the cell lysis buffer (50 mM Tris-HCl [pH 7.5], 300 mM NaCl, 0.05% NP40, 5 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, and protease inhibitor cocktail). Lysates (30-50 µg total protein) were electrophoresed on an 8%-10% SDS-polyacrylamide gel, and then the resolved proteins were transferred onto a PVDF (polyvinylidene difluoride) membrane. Membranes were blocked with 5% skim milk in Tris-buffered saline (TBS) with 0.1% Tween 20 and incubated with primary antibodies against REC8 (1:3,000), RAD21 (1:5,000), SMC3 (1:5,000), OCT3/4 (1:3,000), and α-TUBULIN (1:10,000) overnight at 4°C. Membranes were washed with TBS containing 0.1% Tween 20 three times for 10 min and incubated with the secondary antibody for 1 h at 23°C. The membranes were washed three times with TBST (TBS with 0.1% Tween 20) for 10 min each and developed using an ECL system (170-5061; Bio-Rad, USA) according to the manufacturer’s directions. Immunoblot detection was conducted using the ChemiDoc MP Imaging system (Bio-Rad).
Quantitative PCR was used for analyzing the expression levels of the target genes. SYBR Green (K-6251; Bioneer) and the CFX Connect Real-Time PCR system (1855201; Bio-Rad) were used for the experiments. The sequences of the primers used are listed in Supplementary Table S1.
Data were analyzed using the Prism 5 software (GraphPad Software, USA) and are illustrated as mean ± SD. Statistically significant differences between various groups were measured using the Student’s
The RNA-Seq data were deposited into the NCBI Sequence Read Archive. All the RNA-Seq reads are available under the following accession numbers: SRX10686134 (https://www.ncbi.nlm.nih.gov/sra/?term=SRX10686134), SRX10686135 (https://www.ncbi.nlm.nih.gov/sra/?term=SRX10686135), SRX10686136 (https://www.ncbi.nlm.nih.gov/sra/?term=SRX10686136), and SRX10686137 (https://www.ncbi.nlm.nih.gov/sra/?term=SRX10686137).
The ultimate role of stem cells is defined in terms of their developmental capacity measured by their differentiation ability (Choi et al., 2020; Zhang and Wang, 2008). The role of cohesin against ESC differentiation has previously been shown (Choi et al., 2022; Khaminets et al., 2020; Noutsou et al., 2017), but whether changes in gene expression are a cause or consequence of promoting ESC self-renewal remains unclear. To define the role of cohesin in regulating ESC differentiation, we depleted the core subunit SMC3 and the kleisin subunit RAD21. We additionally depleted the meiotic cohesin component REC8, which was recently shown to play diverse roles in ESCs (Choi et al., 2022). Depletion of each factor was conducted by treating siRNAs against SMC3, RAD21, and REC8 in ESCs. To investigate the role of cohesin in ESC differentiation, we asked whether knocking down each cohesin subunit promoted ESC differentiation (Fig. 1A). To identify protein expression level, we conducted western blot analysis to examine the knockdown efficiency of cohesin as well as the expression level of OCT3/4, which is commonly used as a stem cell marker. (Fig. 1B). The knockdown efficiency of each cohesin subunit in ESCs was higher than 50%, compared with the subunit levels in the siControl condition (Supplementary Fig. S1A). Additionally, knocking down each cohesin subunit did not influence the expression levels of the other subunits (Supplementary Fig. S1B). Interestingly, relative expression levels of OCT3/4 to GAPDH were drastically decreased in cohesin-knockdown conditions compared with the levels in the control group, meaning that each cohesin subunit, especially RAD21 and SMC3, somehow decreases the level of OCT3/4, raising the possibility that it stimulates the differentiation of ESCs (Fig. 1C; Choi et al., 2022). Further, we investigated quantitative PCR to identify the expression pattern of pluripotency transcription factors OCT3/4, SOX2, KLF4, and NANOG in cohesin-knockdown conditions. As shown in the western blot results, we found decreased expression of the stemness markers in cohesin-knockdown conditions. Whereas every cohesin-knockdown condition showed decreased expression of pluripotency transcription factors, si
Several studies have suggested the role of cohesin in changing chromatin architecture, especially those of key self-renewal–related genes (Haering and Jessberger, 2012; Kagey et al., 2010; Noutsou et al.,2017; Sofueva et al., 2013). As the knockdown of each cohesin subunit promoted ESC differentiation, mRNA sequencing (RNA-seq) was performed to verify the differences in global gene expression patterns between the control and cohesin-knockdown groups. To minimize the possibility of misinterpretations, we analyzed RNA-seq data from two independent experiments. PCA (principal component analysis) was used to interpret the suitability of the two independent experiments as biological replicates, as well as the association between each sample (Fig. 2A). The similarity between the two independent groups was high enough to use them as biological replicates, and each group showed distinct distances between one another, meaning that each group has a different gene expression pattern (Supplementary Fig. S2). For further study, a Venn diagram displaying the upregulated and downregulated transcripts was generated based on the normalized data with FPKM > 1, fold change > 1.5, and
The correlation of cohesin with differentiation has been studied by several groups (Galeev et al., 2016; Khaminets et al., 2020; Viny et al., 2019), yet the role of cohesin in controlling ESC differentiation has not been elucidated. As we identified the fact that cohesin regulates the differentiation pattern, we decided to assess the genes whose expression was differentially regulated in each cohesin subunit knockdown condition. To investigate the differentiation pattern in the context of cohesin loss, we decided to analyze the genes whose expression levels are differentially regulated in the si
To identify if REC8 knockdown induces circulatory system development, we classified five related GO terms to understand the gene expression pattern of each group. The five terms are as follows: positive regulation of cell differentiation, anatomical structure formation involved in morphogenesis, blood vessel morphogenesis, vasculature development, and circulatory system development. The set-to-set analysis was performed to understand the correlation among the five groups. “Blood vessel morphogenesis,” “vasculature development,” and “circulatory system development” showed high intensity, as these terms could be grouped by the term “angiogenesis.” Intriguingly, the genes enriched in the term “anatomical structure formation involved in morphogenesis” showed a strong correlation with angiogenesis-related groups, as mentioned above. Indeed, a heatmap of leading-edge genes in each group revealed a fair number of genes co-regulated in each group (Fig. 3D). Meanwhile, groups of genes in positive regulation of cell differentiation with other groups showed a lower intensity of interaction, showing a relatively less overlap among the leading-edge genes (Fig. 3C). To test which genes are in charge of regulating lineage-specific differentiation, a heatmap of leading-edge genes in each group was generated (Fig. 3D). Above all, the
As each GO term contains redundant overlapping genes, we analyzed each GO term and chose two terms that represent functional attributes of the si
Although ESC is characterized by pluripotency and self-renewal, our result reveals that knocking down cohesin in ESC induces lineage-specific differentiation
ESCs in each cohesin subunit knockdown condition were further differentiated to characterize the identity of final differentiated cell populations. For this analysis, we used real-time PCR to determine whether differentiated cells in the cohesin-knockdown conditions express lineage-specific markers. Neural and germline lineage markers turned out to be highly expressed in differentiated cells of the si
Since the development of the methods that control the differentiation of ESCs into specific lineages is of interest, the field of stem cell research has been the center of attention given the ability of ESCs to differentiate into every somatic cell type in the embryo proper. With the expectation of serving as an everlasting cell source to generate functional cells, the harnessing of ESCs is considered a promising therapeutic strategy to treat diverse human diseases. Therefore, several studies are being done to improve the effectiveness of differentiation of ESCs into specific cell types (Gamage et al., 2016; Potter et al., 2014; Willerth et al., 2006). The major limitations of this strategy are that the properties of ESCs and differentiated cells are not described in detail (Choumerianou et al., 2008; Steinbeck and Studer, 2015).
The cohesin complex is a multi-functional complex that exerts various biological processes ranging from organizing chromosome dynamics to controlling self-renewal activity and differentiation of ESCs. Several studies have described the correlation between cohesin and cell differentiation (Mazzola et al., 2019; Sasca et al., 2019), but its exact role in regulating ESC differentiation remains unclear. Through functional analysis of cohesin knockdown conditions, our findings suggest the novel role of cohesin that may function to maintain the balance of self-renewal and differentiation. By using four transcriptional factors that are known to be essential for maintaining the pluripotency of ESCs—Oct4 (Pou5f1), Nanog, Sox2, and Klf4 (Han et al., 2021; Takahashi and Yamanaka et al., 2006)—we aimed to identify the role of cohesin in the pluripotency of ESCs. Knockdown of each cohesin subunit showed decreased expression of pluripotency markers, but among them, si
As the role of cohesin in regulating self-renewal genes has been reported by several researchers, our identification has its further focus on the detailed networks between reduced expression of cohesin and the pattern of differentiation. Using RNA-seq, we performed the first transcriptomic analysis of ESCs in the cohesin-knockdown conditions and observed a significant association between each cohesin subunit knockdown and differentiation to a specific cell type. To address the global gene expression pattern, we identified the genes that were co-regulated in the cohesin-knockdown condition using the DAVID tool. DAVID analysis showed that genes that are up- or down-regulated showed highly enriched biological terms related to differentiation. As SMC3 is the core subunit of cohesin, we decided to analyze the si
Since differentiated cells exhibit specific genes that produce the proteins characteristic for each type of cell, we decided to use lineage markers to determine whether the cohesin-knockdown conditions regulate the lineage specification of differentiation or not. By using two markers for each lineage, we identified the expression levels of lineage-specific markers by comparing RNA-sequencing data of undifferentiated cells and quantitative PCR data of differentiated cells. The RNA-sequencing data revealed that except for the endothelium lineage marker GATA4, which showed a slight downregulation in the si
Taken together, our results indicate that these networks significantly contribute to the lineage differentiation of ESCs which is considered a major challenge for the clinical application of stem cells. While we cannot ignore the constraints of any unrevealed signaling pathway and its applicability
This work was supported by grants from the National Research Foundation of Korea, funded by the Ministry of Science, ICT & Future Planning (No. 2020R1A2C2011887; 2018R1D1A1B07050755), the Korea Environment Industry & Technology Institute through “Digital Infrastructure Building Project for Monitoring, Surveying and Evaluating the Environmental Health Program (No. 2021003330007)” funded by Korea Ministry of Environment, and the BioGreen 21 Program (No. PJ015708) funded by Rural Development Administration, Republic of Korea.
Y.E.K. performed the experiments. Y.E.K., E.H.C., J.W.K., and K.P.K. analyzed the data. K.P.K. conceived and supervised the study. All authors wrote and edited the manuscript.
The authors have no potential conflicts of interest to disclose.
Song Baek, Na Rae Han, Jung Im Yun, Jae Yeon Hwang, Minseok Kim, Choon Keun Park, Eunsong Lee, and Seung Tae Lee
Mol. Cells 2017; 40(2): 117-122 https://doi.org/10.14348/molcells.2017.2223Ling Juan Qiao, Kyung Lhi Kang, and Jung Sun Heo*
Mol. Cells 2011; 32(5): 437-444 https://doi.org/10.1007/s10059-011-0107-6Hyun Nam, Jaewon Kim, Jaewan Park, Joo-Cheol Park, Jung-Wook Kim, Byoung-Moo Seo, Jae Cheoun Lee, and Gene Lee*
Mol. Cells 2011; 31(4): 355-360 https://doi.org/10.1007/s10059-011-0045-3